BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3107125)

  • 21. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/intermediate of beta-lactam hydrolysis.
    Chen CC; Rahil J; Pratt RF; Herzberg O
    J Mol Biol; 1993 Nov; 234(1):165-78. PubMed ID: 8230196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial properties and atomic resolution X-ray complex crystal structure of a ruthenocene conjugated β-lactam antibiotic.
    Lewandowski EM; Skiba J; Torelli NJ; Rajnisz A; Solecka J; Kowalski K; Chen Y
    Chem Commun (Camb); 2015 Apr; 51(28):6186-9. PubMed ID: 25753149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Certain monocyclic beta-lactams are beta-lactamase substrates: nocardicin A and desthiobenzylpenicillin.
    Pratt RF; Anderson EG; Odeh I
    Biochem Biophys Res Commun; 1980 Apr; 93(4):1266-73. PubMed ID: 6772177
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
    Adediran SA; Deraniyagala SA; Xu Y; Pratt RF
    Biochemistry; 1996 Mar; 35(11):3604-13. PubMed ID: 8639512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural relationship between the active sites of β-lactam-recognizing and amidase signature enzymes: convergent evolution?
    Pratt RF; McLeish MJ
    Biochemistry; 2010 Nov; 49(45):9688-97. PubMed ID: 20977193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
    Semenitz E
    Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling study on a hydrolytic mechanism of class A beta-lactamases.
    Ishiguro M; Imajo S
    J Med Chem; 1996 May; 39(11):2207-18. PubMed ID: 8667364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics.
    Wiedemann B
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():31-8. PubMed ID: 3491818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Lactamases and their inhibition.
    Ross GW
    Biochem Soc Trans; 1984 Aug; 12(4):582-4. PubMed ID: 6333361
    [No Abstract]   [Full Text] [Related]  

  • 32. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS; Ishii Y; Galleni M; Ishiguro M; Yamaguchi K; Frère JM; Matsuzawa H; Sakai H
    Biochemistry; 2003 Sep; 42(36):10634-43. PubMed ID: 12962487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
    Pernot L; Frénois F; Rybkine T; L'Hermite G; Petrella S; Delettré J; Jarlier V; Collatz E; Sougakoff W
    J Mol Biol; 2001 Jul; 310(4):859-74. PubMed ID: 11453693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of antibiotic production and public health problems.
    Mansford KR; Slocombe B
    Chemioterapia; 1987 Jun; 6(3):234-40. PubMed ID: 3496977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of beta-lactamases against beta-lactams.
    Stratton CW
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():23-35. PubMed ID: 3062002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X; Minasov G; Shoichet BK
    Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
    Trehan I; Beadle BM; Shoichet BK
    Biochemistry; 2001 Jul; 40(27):7992-9. PubMed ID: 11434768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillin-resistant Staphylococcus aureus bacterium.
    Thumanu K; Cha J; Fisher JF; Perrins R; Mobashery S; Wharton C
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10630-5. PubMed ID: 16815972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of tazobactam with Staphylococcus aureus PC1 beta-lactamase: a molecular modelling and enzyme kinetics study.
    Denny BJ; Toomer CA; Lambert PA
    Microbios; 1994; 78(317):245-57. PubMed ID: 8078414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC1 beta-lactamase crystal structure.
    Boissinot M; Levesque RC
    J Biol Chem; 1990 Jan; 265(2):1225-30. PubMed ID: 2295609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.